Literature DB >> 1500159

Granulocyte-macrophage colony-stimulating factor increases the infectivity of Leishmania amazonensis by protecting promastigotes from heat-induced death.

M A Barcinski1, D Schechtman, L G Quintao, D de A Costa, L R Soares, M E Moreira, R Charlab.   

Abstract

We have studied the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on the infectivity of promastigotes of Leishmania amazonensis, an obligate intramacrophage parasite. We measured the capacity of the promastigotes to infect macrophages after preincubation at different temperatures (28, 34, and 37 degrees C) with recombinant murine GM-CSF, as well as the effect of an anti-murine GM-CSF antibody on the in vitro and in vivo infectivity of the parasite. GM-CSF increases the capacity of the promastigotes to infect cells when preincubated at 34 and 37 degrees C, whereas the anti-GM-CSF antibody exerts the opposite effect: it decreases the internalization rate and the progression of infection in macrophage cultures and slows the growth of the lesion in infected BALB/c mice. Neither of the described effects were observed when the in vitro and in vivo infections were made with amastigotes. Promastigotes die in a time-dependent manner when incubated at temperatures higher than 28 degrees C in the absence of GM-CSF. They are protected from this heat-induced death by incubation with the recombinant hormone. Our interpretation of these data is that the increase in the infectivity of promastigotes when incubated with GM-CSF at the temperatures at which infection occurs (34 and 37 degrees C) is due to the larger number of surviving forms within the infecting population. The decrease in infectivity when they are incubated with the antibody is due to inhibition of the protection conferred by the GM-CSF produced by the macrophages during the in vitro and in vivo infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500159      PMCID: PMC257355          DOI: 10.1128/iai.60.9.3523-3527.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  In vitro and in vivo effects of interleukin 2 on the protozoan parasite leishmania.

Authors:  C Mazingue; F Cottrez-Detoeuf; J Louis; M Kweider; C Auriault; A Capron
Journal:  Eur J Immunol       Date:  1989-03       Impact factor: 5.532

2.  Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity.

Authors:  R G Titus; J M Ribeiro
Journal:  Science       Date:  1988-03-11       Impact factor: 47.728

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.

Authors:  D L Sacks; S Hieny; A Sher
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

5.  Corticotropin and beta-endorphin-like materials are native to unicellular organisms.

Authors:  D Leroith; A S Liotta; J Roth; J Shiloach; M E Lewis; C B Pert; D T Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  HSP104 required for induced thermotolerance.

Authors:  Y Sanchez; S L Lindquist
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

7.  Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation.

Authors:  B Thorens; J J Mermod; P Vassalli
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

8.  Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages.

Authors:  E Handman; A W Burgess
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

9.  Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis.

Authors:  J O Hill; R J North; F M Collins
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

10.  Application of recombinant granulocyte-macrophage colony-stimulating factor has a detrimental effect in experimental murine leishmaniasis.

Authors:  J Greil; B Bodendorfer; M Röllinghoff; W Solbach
Journal:  Eur J Immunol       Date:  1988-10       Impact factor: 5.532

View more
  10 in total

1.  Insulin-like growth factor (IGF)-I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis.

Authors:  C M Gomes; H Goto; V L Ribeiro Da Matta; M D Laurenti; M Gidlund; C E Corbett
Journal:  Int J Exp Pathol       Date:  2000-08       Impact factor: 1.925

2.  Antileishmanial activity of the terpene nerolidol.

Authors:  Denise C Arruda; Fabio Luiz D'Alexandri; Alejandro M Katzin; Silvia R B Uliana
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Increased C3 production in human monocytes after stimulation with Candida albicans is suppressed by granulocyte-macrophage colony-stimulating factor.

Authors:  A K Høgåsen; T G Abrahamsen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Insulin-like growth factor I is a growth-promoting factor for Leishmania promastigotes and amastigotes.

Authors:  H Goto; C M Gomes; C E Corbett; H P Monteiro; M Gidlund
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

5.  Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.

Authors:  H W Murray; J S Cervia; J Hariprashad; A P Taylor; M Y Stoeckle; H Hockman
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

Review 6.  Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases.

Authors:  Luiza C Reis; Eduardo Milton Ramos-Sanchez; Fernanda N Araujo; Ariane F Leal; Christiane Y Ozaki; Orlando R Sevillano; Bernardina A Uscata; Hiro Goto
Journal:  J Immunol Res       Date:  2021-05-04       Impact factor: 4.818

7.  Exposure of phosphatidylserine on Leishmania amazonensis isolates is associated with diffuse cutaneous leishmaniasis and parasite infectivity.

Authors:  Jaqueline França-Costa; João Luiz Mendes Wanderley; Poliana Deolindo; Jessica B Zarattini; Jackson Costa; Lynn Soong; Marcello André Barcinski; Aldina Barral; Valeria M Borges
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

8.  Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice.

Authors:  Danilo C Miguel; Jenicer K U Yokoyama-Yasunaka; Silvia R B Uliana
Journal:  PLoS Negl Trop Dis       Date:  2008-06-11

9.  Modulation of Leishmania (L.) amazonensis Growth in Cultured Mouse Macrophages by Prostaglandins and Platelet Activating Factor.

Authors:  M V Lonardoni; C L Barbieri; M Russo; S Jancar
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

10.  Endothelin-1 Stimulates Monocytes in vitro to Release Chemotactic Activity Identified as Interleukin-8 and Monocyte Chemotactic Protein-1.

Authors:  E Helset; T Sildnes; Z S Konopski
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.